Assessment of the Relationship Between Cerebral Blood Flow and Heart Rate
Launched by UNIVERSITY OF CALGARY · May 14, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how heart rate affects blood flow in a specific part of the brain called the middle cerebral artery (MCA). Researchers want to understand the connection between how fast the heart beats and how well blood flows through this artery, which is important for brain health. To do this, they will recruit patients who are already scheduled for certain heart procedures. During these procedures, doctors will use a temporary device to control the heart rate while measuring blood flow in the MCA with a special ultrasound.
To participate in this study, you need to be between 18 and 70 years old and scheduled for a heart procedure where a device will be placed in your heart. You should also have a good heart function, as indicated by a measurement called left ventricular ejection fraction. If you join the trial, you can expect to have your heart rate adjusted during the procedure while researchers monitor your blood flow. It’s important to note that participants must be able to give their consent and travel to the Cardiac Electrophysiology Laboratory in Calgary, Canada.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female
- • Age 18-70 years, inclusive
- • Scheduled for clinically indicated elective electrophysiological studies where temporary pacing catheters are being placed in the right atrium
- • Left ventricular ejection fraction ≥50%
- • Able and willing to provide informed consent
- • Able to travel to the Cardiac Electrophysiology Laboratory at the Foothills Medical Centre, Calgary, Alberta, Canada
- Exclusion Criteria:
- • Unable or unwilling to provide informed consent
- • Other factors which in the investigator's opinion would prevent the participant from completing the protocol
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Patients applied
Trial Officials
Satish R Raj, MD MSCI
Principal Investigator
University of Calgary
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials